hansoh glp 1 Merck strikes a $2B GLP-1 deal with Merck strikes partnership worth $1.9
Description
Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R
GLP-1 receptor agonists work by mimicking the action of endogenous incretin hormones, which are released from the gut in response to food intake
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
In addition to achieving significant weight loss, research has shown that GLP-1 drugs can reduce the risk of major cardiovascular events such as heart attack or stroke in people with Type 2 diabetes
